Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET-Reference-Cited by-同舟云学术

Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET

Published:2013-12-12 Issue:1 Volume:55 Page:23-29
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Mortimer Joanne E.,Bading James R.,Colcher David M.,Conti Peter S.,Frankel Paul H.,Carroll Mary I.,Tong Shan,Poku Erasmus,Miles Joshua K.,Shively John E.,Raubitschek Andrew A.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference24 articles.

1. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

2. Current approaches and future directions in the treatment of HER2-positive breast cancer

3. HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer

4. HER2Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

5. Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress;Diagnostics;2024-09-03

2. Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11

3. Advances and challenges in immunoPET methodology;Frontiers in Nuclear Medicine;2024-02-19

4. Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab;American Journal of Nuclear Medicine and Molecular Imaging;2024

5. ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications;Cancers;2023-12-18